6,7-二氧代-4-芳胺香豆素的设计、合成及分子对接研究

茶酚-氧位-甲基转移(COMT)酶抑制剂在治疗帕金森病中起到重要作用.通过对现有COMT酶抑制剂托卡朋和恩托卡朋结构与活性关系分析,推断含有儿茶酚结构的香豆素类化合物可能具有潜在的COMT酶抑制活性,因此设计合成了一类新型的6,7-二氧代-4-芳胺香豆素,通过理论计算,研究了此类化合物对COMT酶抑制活性.结果表明,设计的10种6,7-二氧代-4-芳胺香豆素与COMT酶的对接效果均较好,其中具有甲氧基乙基保护的儿茶酚结构化合物6,7-二[2-(甲氧基)乙氧]-4-(苯胺)香豆素(6b4)和6,7-二[2-(甲氧基)乙氧]-4-[(3-乙炔基)苯胺]香豆素(6b5)与COMT酶的对接效果尤为显著.     

6,7-二甲氧基喹啉衍生物的合成及体外抗肿瘤活性研究

以3,4-二甲氧基苯胺和丙二酸为原料,经过多步反应合成得到一系列6,7-二甲氧基喹啉衍生物(3～7b),中间体及产物结构经~1H NMR和ESI-MS表征。并着重考察了Suzuki反应中,物料比对化合物5a和5b收率的影响,确定适宜物料比为n(化合物4)∶n(乙烯基硼酸频哪醇酯)=1∶2.0。在该反应条件下,化合物5a和5b收率分别为54.5%和33.8%。采用MTT法测定6,7-二甲氧基喹啉衍生物3～7b对人肝癌细胞HepG2及人非小细胞肺癌A549的体外抗肿瘤活性。结果表明,化合物7b对HepG2细胞的体外生长具有显著的抑制活性,IC_(50)为8.9±0.95μM·L~(-1)。     

4-[2-(1-哌嗪基)-4-氨基-6,7-二甲氧基喹唑啉基]-3-甲氧基-D-肌醇的合成

以右旋肌醇甲醚为原料,经缩酮化、磺酸酯化、酸解脱保护、缩合等反应合成了4-[2-(1-哌嗪基)-4-氨基-6,7-二甲氧基喹唑啉基]-3-甲氧基-D-肌醇,此方法具有条件温和、便于操作和产率高等特点。利用波谱分析和元素分析对中间体和标题化合物进行了结构确定。     

4(3H)-喹唑啉酮芳胺衍生物的合成及其抗肿瘤活性评价

根据非经典抗叶酸剂的结构特点,将抗肿瘤药效团三甲氧基苯基与4(3H)-喹唑啉酮结构相结合,设计了一系列具有芳胺侧链的4(3H)-喹唑啉酮衍生物。使用适量的卤代烷,在室温下对3．4,5-三甲氧基苯胺进行N-烷基化反应,制得了4种N-取代的3,4,5-三甲氧基苯胺,收率为30．3％～60．6％。将2-甲基-6-溴甲基-4(3H)-喹唑啉酮与3,4,5-三甲氧基苯胺、N-取代的3,4．5-三甲氧基苯胺以及其它芳胺在室温下反应,以30．8％～71．9％的收率合成了目标化合物8a～8m,其结构用ESI-MS、~1H NMR、元素分析或HRMS测试技术进行了表征。采用MTF法测试了化合物8a～8m对人非小细胞肺癌A-549、结肠癌HCT-8和肝癌Bel-7402细胞的体外抗肿瘤活性。结果表明,在5×10~(-6)g/mL质量浓度下所合成的化合物对3种肿瘤细胞的体外生长的抑制率均低于25％。     

三苯胺类小分子的合成及其AIE性能研究

以二苯胺、碘苯、对碘甲苯以及对碘苯甲醚为原料,合成了三苯胺及其衍生物T1~T5(4-甲氧基三苯胺、4-甲基三苯胺、4-醛基三苯胺、4-乙烯基三苯胺),并对其紫外-可见吸收光谱与荧光光谱进行了检测。结果表明,连有甲氧基、甲基、乙烯基取代基的三苯胺化合物在甲醇/氯仿混合溶液中具有聚集诱导发光(AIE)性能;而醛基取代的4-醛基三苯胺表现出了聚集荧光猝灭(ACQ)现象。     

全叶马兰中两个新的黄酮类化合物

利用多种色谱分离方法对全叶马兰(Kalimeris integrifolia)的化学成分进行研究,从其地上部分的乙醇提取物中分离得到两个化合物,应用HR-ESIMS,1D和2D NMR,IR,UV等多种波谱技术确定了化合物的化学结构,经鉴定分别为5,8-二羟基-2-(3-羟基-4,5-二甲氧苯基)-6,7-二甲氧基-4H-色烯-4-酮(1)和5-羟基-6,7-二甲氧基-2-(4'-甲氧基苯基)-4-氧代-4H-色烯-8-(2'-甲基丁酸酯)(2).化合物1和2为两个新的黄酮类化合物.     

6-位修饰的吉非替尼衍生物合成及细胞毒活性研究

以2-氨基-4,5-二甲氧基苯甲酸为起始原料,经关环,选择性脱甲基,醋酸酐保护,氯代,与3-氯-4-氟苯胺取代,去保护得到关键中间体4-(3-氯-4-氟苯胺)-7-甲氧基-喹唑啉-6-醇.再经过6-位羟基成醚、成酯反应合成了共计23个吉非替尼衍生物.所有目标化合物通过IR,1H NMR,13C NMR,HRMS等结构确证.并采用四甲基偶氮唑盐(MTT)法对所得目标化合物进行了细胞毒活性测试,结果发现部分化合物具有一定的抑制活性,其中化合物7b,7c,7d,8a,8m抑制人非小细胞肺癌细胞(A549)增殖活性和化合物7c,8m抑制人肝癌细胞(Hep G-2)增殖活性与吉非替尼相当.     

4-苯胺喹唑啉类化合物合成研究进展

4-苯胺喹唑啉类化合物是一类具有广泛药理活性的喹唑啉类生物碱,在酪氨酸激酶受体(EGFR)抑制剂的研发中具有重要的作用。已经上市的此类药物有吉非替尼(gefitinib)和厄洛替尼(erlotinib)等。此类化合物的合成都是经过喹唑啉酮中间体或直接环合成4-苯胺喹唑啉。苯甲醛及其衍生物被用作反应原料,两种合成路线都要经历对苯甲醛的硝化及硝基的还原两步反应。笔者经查阅资料,设计并验证了以苯胺为原料、经靛红中间体得到4-苯胺喹唑啉类化合物的新的合成路线。本文依据这两种合成策略综述了4-苯胺喹唑啉类化合物的合成方法,并对各种方法的优缺点进行了总结,为进一步研究4-苯胺喹唑啉合成及设计具有药理活性的新化合物提供参考。     

6-甲氧基喹唑啉酮-吡啶二氟硼染料的合成及发光性能研究（英文）

以5-甲氧基-2-氨基苯甲酰胺与2-甲基吡啶为原料,通过简单的两步反应合成了6-甲氧基喹唑啉酮-吡啶二氟硼化合物(BODIQPy).这种甲氧基取代的BODIQPy具有良好的溶液荧光和固态发光性质.通过甲氧基的引入,增强了BODIQPy的电荷转移特性,得到了超大斯托克斯位移.同时还讨论了5-位吡啶取代的卤素对BODIQPy发光性质的影响.     

2,3-二氢喹唑啉-4(1H)-酮类化合物的合成研究进展

2,3-二氢喹唑啉-4(1H)-酮是一类重要的含氮稠杂环化合物,具有广泛的药理及生物活性,在药物合成与研发领域有着重要应用价值,因而其合成方法也倍受人们关注.归纳总结了2,3-二氢喹唑啉-4(1H)-酮类化合物的合成研究进展,主要介绍了以邻氨基苯甲酰胺、靛红酸酐、邻硝基苯甲酰胺、邻叠氮基苯甲酰胺、邻溴苯甲酰胺、邻溴苯甲腈、邻氨基苯甲酸、邻氨基苯甲腈、邻氨基N-甲基-N-丙二烯基苯甲酰胺、N-烷基苯胺等为起始原料的2,3-二氢喹唑啉-4(1H)-酮类化合物的合成研究进展概况及其反应机理.最后对该类化合物的合成研究进展进行了总结,并对其发展前景进行了展望.     

Synthesis, reactions, and biological activity of 1,4-benzothiazine derivatives

Abstract  

6,7-Dimethoxy-2H-1,4-benzothiazin-3(4H)-one reacts with dimethylformamide dimethylacetal (DMF-DMA) to give the novel enaminone 2-(dimethylaminomethylene)-6,7-dimethoxy-2H-1,4-benzothiazin-3(4H)-one. The reaction of the latter with various active methylene compounds afforded pyrido[3,2-b][1,4]benzothiazines. Also, coupling of the enaminone with diazotized aniline derivatives gave 2-(arylhydrazono)-6,7-dimethoxy-2H-1,4-benzothiazin-3(4H)-ones. Spectral data indicated that the latter compounds exist predominantly in the hydrazone tautomeric form. In addition, coupling of the enaminone with diazotized heterocyclic amines afforded tetra- and pentaheterocyclic ring systems. The antitumor and antimicrobial activity of some of the synthesized compounds was screened.     

A short and unequivocal synthesis of 5-aminotetrazolo[1,5-a]-quinazoline as a tricyclic analogue of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035)

The discovery of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035) as an extremely potent inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor led to the preparation of several fused tricyclic quinazoline analogues. The present paper reports a new tricyclic derivative: 5-(3-bromoanilino)-7,8-dimethoxytetrazolo[1,5-a]quinazoline. This compound was synthesized by two different pathways viaa 1,3-dipolar cycloaddition of an azide at carbon 2 of the quinazoline ring.     

Synthesis and biological study of novel 5-{(4-(6,7-dihydrothieno-[3,2-c]pyridin-5(4H)-ylsulfonyl)phenylamino)-methyl}quinolin-8-ol and its metal complexes

A novel 5-((4-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-ylsulfonyl)phenylamino)methyl)quinolin-8-ol(HTPSMQol) was synthesized by optimized reaction of 4-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-ylsulfonyl)aniline with 5-chloromethyl-8-hydroxy-quinoline hydrochloride(CMHQ).Also complexes of HTPSMQol were prepared by using various M(Ⅱ) metal salts.All compounds were analyzed by spectroscopic techniques and screened against various strains of microorganisms.The results showed higher antimicrobial activity of HTPSMQol compared to its metal complexes and comparable with Ciprofloxacin.     

Dimethylformamide Catalyzed Synthesis of Novel Heterocycles—Their Characterization and Antimicrobial Evaluation

Indandione 1 was brominated to yield 2‐bromoIndandione 2 , which further reacted with substituted thiocarbamides, carbamides, 2‐aminothiophenols, 2‐aminophenol, and triazole to furnished 3‐substituted aniline‐2‐thia‐4‐aza‐6,7‐benzo‐8‐oxo‐bicyclo[3.3.0]‐1(5),3‐octadiene 3 , 3‐substituted aniline‐2‐oxa‐4‐aza‐6,7‐benzo‐8‐oxo‐bicyclo[3.3.0]‐1(5),3‐octadiene 4 , 2‐Thia‐5‐aza‐9‐oxo‐3,4‐(3′‐substituted) benzo‐7,8‐benzo‐bicyclo[4.3.0]‐1(6) nonene 5 , 2‐oxa‐5‐aza‐9‐oxo‐(3, 4)‐(7,8)‐dibenzo‐bicyclo[4.3.0]‐1(6) nonene 6 , 3′‐substituted‐(1′,2′,4′)triazolo[5,6‐b][indeno(2,3‐e)]‐1,3,4‐thiadiazine 7 , respectively. The structures of compounds were elucidated on the basis of spectral techniques, further the representative compounds were screened for their antimicrobial activity.     

香豆素冠醚双功能化杯[4]芳烃的合成

以对叔丁基杯[4]芳烃为原料,经碱催化合成了26,28-双(4,7-双甲氧基香豆素)-5,11,17,23-四叔丁基杯[4]-冠-6(2)。其结构经1H NMR,IR和元素分析表征,2为锥形结构。     

Four new isoflavonoids from the stem bark of Erythrina variegata

Bioassay-directed fractionation of the stem bark extract of Erythrina variegata L. has resulted in the isolation of three new isoflavones: 5,4'-dihydroxy-8-(3,3-dimethylallyl)-2'-methoxyisopropylfurano[4,5:6,7]isoflavone (1), 5,7,4'-trihydroxy-6-(3,3-dimethylallyloxiranylmethyl)isoflavone (2), 5,4'-dihydroxy-8-(3,3-dimethylallyl)-2'-hydroxymethyl-2'-methylpyrano[5,6:6,7]isoflavone (3) and a new isoflavanone, 5,4'-dihydroxy-2'-methoxy-8-(3,3-dimethylallyl)-2',2'-dimethylpyrano[5,6:6,7]isoflavanone (4) together with seven known compounds, euchrenone b10 (5), isoerysenegalensein E (6), wighteone (7), laburnetin (8), lupiwighteone (9), erythrodiol (10), and oleanolic acid (11). The structures were determined on the basis of spectroscopic analyses and chemical evidence. The effect of these compounds on the proliferation of rat osteogenic sarcoma (UMR106) is also reported.     

Rearrangements in the haloalkoxy(thio,amino)-sym-triazine series. 10. Synthesis and rearrangement of 2-dimethylamino-4-(2-acylhydrazino)-6,7-dihydrooxazolo[3,2-a]-sym-triazines

2-Dimethylamino-4-(2-acetylhydrazino)- and 4-(2-benzoyl)hydrazino-6,7-dihydrooxazolo[3,2-a]-sym-triazines were synthesized. It was established that when these compounds are heated, they undergo rearrangement to the corresponding 2-dimethylamino-6,7-dihydroimidazo[2,1-a]-sym-triazines. Deacylation of the latter gives the N-amino derivative.Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 12, 1689–1692, December, 1981     

Synthesis,Characterization, and Spectroscopic Properties of Hexa(4-Bromo-2-Formyl-Phenoxy)Cyclotriphosphazene and Hexa(4-Chloro-2-Formyl-Phenoxy)Cyclotriphosphazene and Fully Substituted Cyclotriphosphazene Derivatives Bearing a Schiff Base at Room Temperature

Abstract

Hexa(4-bromo-2-formyl-phenoxy)cyclotriphosphazene (2) and hexa(4-chloro-2- formyl-phenoxy)cyclotriphosphazene (3) were obtained from the reactions of hexachloro- cyclotriphosphazene (1) with 5-bromosalicylaldehyde and 5-chlorosalicylaldehyde in the presence of (C₂H₅)₃N and K₂CO₃ at room temperature, respectively. The new two organocyclotriphosphazenes bearing formyl groups were reacted with 4-cyano aniline, 2-phenyl aniline, 4-aceto aniline, 5-chloro-2-hydroxy aniline, 2-hydroxy aniline, 4-hydroxy aniline, 2-(4-morpholino)ethyl amine, 4-carboxy aniline, 4-carbomoyl aniline, 2-mercapto aniline, and 5-amino isoquonoline to prepare cyclotriphosphazene derivatives containing a Schiff base at room temperature. However, fully phenoxy-substituted cyclotriphosphazenes containing a Schiff base were isolated from the reactions of the compound 2 and 3 with 5-chloro-2-hydroxy aniline, 2-hydroxy aniline, 4-hydroxy aniline, and 2-(4-morpholino)ethyl amine. The structures of the synthesized compounds were characterized by elemental analysis, IR, and NMR (¹H, ¹³C, ³¹P) spectroscopy. According to the results of the analysis, all synthesized compounds were found to be fully substituted organocyclotriphosphazenes, such as hexa[4-bromo-2-(5-chloro-2-hydroxy-pheyliminomethyl)phenoxy]cyclotriphosphaze (2a). All cyclotriphosphazene derivatives synthesized gave fluorescence emission peaks in range between 300 nm and 410 nm.     

若干D环带硝基的小檗因衍生物的光环化合成

通过酰烯胺的光环化反应, 合成了六个D环带硝基的小檗因类化合物。在酰烯胺的制备中, 还得到了几个非预期的副产物, 阐明了它们的结构。     

One‐pot three‐component synthesis of novel 2‐(3‐nitro‐phenyl)‐quinazoline‐4‐carboxylic acid derivatives

A simple and easy synthesis of 2‐(3‐nitro‐phenyl)‐quinazoline‐4‐carboxylic acid ( 3 ) has been successfully developed through a one‐pot three‐component condensation reaction of (2‐amino‐phenyl)‐oxo‐acetic acid sodium salt ( 1 ) obtained from the hydrolysis of isatin with ammonium acetate and 3‐nitrobenzaldehyde. Some novel quinazoline‐ester derivatives 4‐7 were then obtained by the reaction between the new compound 3 and various alcohols. Then, quinazoline‐amide derivatives 10‐14 were synthesized from the reaction of various amines and 2‐(3‐nitro‐phenyl)‐quinazoline‐4‐carbonyl chloride ( 8 ), obtained by the reaction of compound 3 with SOCl₂. Finally, some novel quinazoline‐azo derivatives 17‐19 were synthesized by the coupling reaction between β‐dicarbonyl compounds and the novel amino‐quinazoline derivative compound 15 , obtained by reduction of nitro‐quinazoline derivative compound 11 . Thus, a new series of quinazoline‐4‐carboxylic acid, ester, amide, and azo derivatives was synthesized and fully characterized by ¹H NMR, ¹³C NMR, IR, and mass spectrometry analysis.